What Is Medical Grade Manuka Honey? Uses & Ratings

Medical grade manuka honey differs from store-bought versions in key ways. Learn how it works, what UMF and MGO ratings mean, and its FDA-cleared uses.

Medical grade manuka honey is manuka honey that has been sterilized and standardized for use in clinical wound care. Unlike the jars you find on grocery shelves, it has been treated with gamma radiation to eliminate bacterial spores without diminishing its antibacterial properties, then tested to confirm its active compound levels meet a specific threshold. The distinction matters because raw honey, even high-quality manuka, can harbor dormant spores that pose a genuine risk when applied to open wounds. The “medical grade” label means the product has cleared the safety and potency bar required for direct contact with damaged tissue.

What Makes It Different from Food Grade Manuka Honey

All genuine manuka honey starts in the same place: bees foraging on the flowers of Leptospermum trees, predominantly in New Zealand and parts of Australia. The chemistry is the same whether the honey ends up in a wound dressing or on your toast. The critical difference is what happens after harvest. Medical grade manuka honey undergoes gamma irradiation, typically at a dose of 25 kGy, which is enough to destroy vegetative bacterial cells and the spores of dangerous organisms like Clostridium without reducing the honey’s antibacterial activity. Research has confirmed that even doubling that radiation dose to 50 kGy causes no significant change in either type of antibacterial activity honey possesses.

Food grade manuka honey is not sterilized in this way. It may be filtered, tested for methylglyoxal content, and graded, but it has not been cleared for wound contact. Applying grocery-store manuka to a cut might still offer some benefit, but it has not gone through the quality controls that matter for serious medical use. Medical grade products are typically sold as impregnated dressings, gels, or ointments rather than in jars, and they carry regulatory clearances in the markets where they are sold.

The Active Ingredient and How It Forms

The antibacterial punch of manuka honey comes primarily from methylglyoxal, usually abbreviated MGO. Most honeys rely on hydrogen peroxide for their antimicrobial effects, a compound produced by the enzyme glucose oxidase. Manuka has that too, but it also has MGO at concentrations many times higher than other honeys. MGO is what researchers call the “non-peroxide” antibacterial activity, and it is the reason manuka outperforms conventional honeys in wound care studies.

MGO does not start out as MGO in the nectar. Bees collect dihydroxyacetone, or DHA, from Leptospermum flowers, and once the honey is harvested, DHA slowly converts into MGO during storage. In fresh manuka honey, the DHA-to-MGO ratio is quite high, but as the honey matures over months, it settles toward roughly a 2:1 ratio of DHA to MGO. Temperature plays a role: higher storage temperatures speed up DHA loss and the initial rate of MGO formation, but cooler temperatures actually produce better overall conversion efficiency. This maturation process continues for at least a year after extraction, which means a jar tested at harvest and the same jar tested twelve months later can have meaningfully different MGO levels.

Beyond MGO, manuka honey contains a suite of phenolic compounds and other unique chemicals, including leptosperin, glyoxal, and methylsyringate, all of which contribute to its bioactivity profile. The antibacterial potency of manuka honey has been linked not just to MGO alone but to the combined effect of MGO and total phenol content.

Understanding UMF and MGO Ratings

If you have ever looked at a manuka honey label, you have likely seen numbers like UMF 10+, UMF 15+, or MGO 250+. These are different rating systems that attempt to quantify the honey’s antibacterial strength, and they overlap in confusing ways.

UMF stands for Unique Manuka Factor. It is a grading system trademarked by the UMF Honey Association in New Zealand, and it measures several chemical markers in the honey, including MGO, DHA, and leptosperin, then assigns a number meant to reflect overall quality and antibacterial potency. MGO ratings, by contrast, simply report the concentration of methylglyoxal in milligrams per kilogram. An MGO 250+ honey, for example, contains at least 250 mg of methylglyoxal per kilogram. Broadly, a UMF 10+ corresponds to roughly MGO 263+, and a UMF 15+ to roughly MGO 514+, though exact equivalencies vary by source.

Leptosperin has emerged as an important authentication marker because it is specific to genuine manuka honey and remains stable during storage, unlike some other compounds whose levels shift over time. A study of certified manuka samples found a strong correlation between leptosperin content and non-peroxide antibacterial activity, suggesting it could serve as a reliable way to confirm authenticity. For medical grade products, the MGO concentration is typically the specification that matters most, since it is the primary antibacterial driver and the number that determines whether the honey meets the threshold for clinical use.

Why a Higher Rating Does Not Always Mean Better Antibacterial Effects

One of the more counterintuitive findings in manuka research is that a higher UMF or MGO number does not automatically translate to stronger bacteria-killing performance. A study comparing manuka honeys of varying UMF grades found that lower-graded honeys sometimes showed equal or even greater antimicrobial activity than higher-graded honeys across multiple organism groups. The researchers attributed this to the dynamic chemistry of manuka honey: because DHA continues converting to MGO after harvest, a honey tested and labeled at one point in time may have a different active profile months later. A “lower-rated” honey that has been aging longer could have more bioavailable MGO than a freshly bottled “higher-rated” one.

The relationship between MGO content and bacterial killing also varies by organism. When researchers tested a collection of commercial manuka honeys against four bacterial species, they found a strong correlation between MGO levels and antibacterial activity for E. coli and Enterococcus faecalis, a moderate correlation for Staphylococcus aureus, and no meaningful correlation at all for Pseudomonas aeruginosa. This suggests that MGO is not the only compound doing work, and that the full antibacterial picture involves phenolics and other factors the rating systems do not fully capture. For practical purposes, a UMF 10+ or MGO 250+ is generally the floor for medical applications, but chasing the highest possible number is not necessarily worth the premium price.

How Medical Grade Manuka Honey Works on Wounds

The wound-healing benefits of manuka honey come from several overlapping mechanisms, not just its ability to kill bacteria. Lab and animal studies show that honey debrides wounds (helps remove dead tissue), lowers wound pH, reduces chronic inflammation, and promotes the migration of fibroblasts, the cells responsible for building new tissue. These effects work together to create an environment that favors healing rather than stagnation.

One of the more clinically relevant findings is manuka honey’s ability to penetrate and destroy biofilms. Biofilms are dense, slimy colonies of bacteria that form on wound surfaces and are notoriously resistant to antibiotics. Research has shown that manuka honey at concentrations achievable in wound dressings can completely eradicate established Pseudomonas aeruginosa biofilms, one of the most stubborn pathogens in chronic wound infections. The anti-biofilm effect was partly driven by honey’s high sugar content, which creates osmotic stress on the bacteria, though MGO and other compounds contribute as well.

On the inflammation side, an animal study found that wounds treated with manuka honey showed a faster shift from the early, aggressive inflammatory phase to the repair-oriented phase of healing. By day ten, treated wounds had lower levels of the pro-inflammatory marker IL-1β and higher levels of the anti-inflammatory marker IL-10 compared to untreated controls, along with improved tissue repair on microscopic examination. The pH-lowering effect also matters: chronic wounds tend to be too alkaline, and the slightly acidic environment honey creates favors cellular repair processes. In lab testing, medical grade honey adjusted to various pH values retained its ability to reduce bacterial survival across all conditions tested, with particularly strong effects against Staphylococcus epidermidis.

Clinical Evidence in Wound Care

The strongest clinical evidence for medical grade manuka honey comes from wound types that are notoriously slow to heal: diabetic foot ulcers, venous leg ulcers, and burns. These are the situations where standard treatments often stall, and where honey’s multiple mechanisms can make a measurable difference.

In a study of patients with neuropathic diabetic foot ulcers, those treated with manuka honey-impregnated dressings healed in an average of about 31 days, compared to roughly 43 days for those receiving conventional dressings. The honey group also saw much faster wound sterilization: about 78% of ulcers were sterile within the first week, compared to about 36% in the control group. Both groups eventually reached similar overall healing rates (around 90-97%), but the speed advantage was substantial.

A similar pattern emerged for venous leg ulcers. Patients receiving topical manuka honey completed healing in up to seven weeks, while those on standard treatment took up to fourteen weeks. The honey group also cleared wound microorganisms faster and showed more rapid reduction in ulcer size.

For burns, a systematic review and meta-analysis pooling results across multiple studies found that honey was more effective than silver-based dressings for wound healing, as measured by the number of days needed for wounds to heal, and showed superior antibacterial qualities. That said, not all medical grade honey products perform identically. A study comparing two commercial honey wound products against silver dressings in burn models found that a supplemented medical grade honey performed on par with silver, while a different manuka-based product (Medihoney) was outperformed. The formulation and any added ingredients can matter as much as the honey itself.

Uses Beyond Wound Dressings

Medical grade manuka honey has been explored in areas well outside traditional wound care, with some promising early results. One recent application is in ophthalmology. A controlled study of patients with dry eye disease following cataract surgery found that those using manuka honey eye drops had a significantly greater reduction in dry eye symptom scores compared to controls at one month, along with measurably less conjunctival redness. The idea of putting honey in your eyes sounds alarming, but the formulations used in these studies are diluted, sterile, and specifically designed for ophthalmic use. These are not products you could make at home with a jar from the pantry.

Veterinary medicine has also adopted medical grade manuka honey. A study of acute full-thickness wounds in dogs found that a manuka honey and essential oil hydrogel produced substantially higher rates of new skin coverage compared to untreated control wounds at multiple time points during healing, without increasing infection risk. Veterinary wound care faces many of the same challenges as human wound care, including antibiotic-resistant bacteria and the difficulty of keeping animals from disturbing their dressings, so honey-based products fill a real niche.

Authenticity and the Challenge of Verifying Real Manuka Honey

Manuka honey commands a steep price premium, and where there is premium pricing there is fraud. More manuka honey is sold globally each year than New Zealand could possibly produce, which means a meaningful portion of what is labeled “manuka” is adulterated or outright fake. Verifying authenticity is an ongoing scientific challenge, and several approaches have been developed to address it.

Chemical marker analysis is the primary tool. MGO content is the most commonly tested marker, but it can be artificially boosted by adding synthetic methylglyoxal to cheaper honey. Leptosperin is harder to fake because it is naturally present in Leptospermum nectar and remains stable during storage, making it a more reliable fingerprint of genuine manuka origin. More advanced methods combine multiple analytical platforms, including mass spectrometry and nuclear magnetic resonance, along with statistical modeling to discriminate genuine manuka from imitations.

DNA analysis adds another layer. By testing for Leptospermum pollen DNA, labs can confirm that bees actually visited the right plant species. A study comparing chemical and DNA markers across New Zealand and Australian manuka honeys found that while most markers were present at similar concentrations in both countries’ products, leptosperin and one other marker (2-MBA) were significantly lower in New Zealand manuka than in Australian manuka. This has regulatory implications: New Zealand and Australia have had ongoing disputes over who gets to use the term “manuka,” and the chemical differences between the two countries’ products are real, even though both come from closely related Leptospermum species. For a consumer buying medical grade manuka honey, the safest approach is to look for products that carry a recognized certification mark like UMF, list a specific MGO level, and come from brands with transparent supply chains. The medical grade products used in clinical settings have already passed more rigorous checks than anything on a retail shelf, which is one more reason why medical grade and food grade are meaningfully different categories despite starting from the same raw material.